APA (7th ed.) Citation

G, D. L., M, A., B, U., D, O., V, G., Z, Z., . . . M, V. (2026). Chronic Treatment with Renin-Angiotensin System Inhibitors at Hospital Admission is Associated with Improved Reperfusion and Mortality Among STEMI Patients Undergoing Mechanical Reperfusion: Insight from the ISACS-STEMI COVID-19 Registry. Current vascular pharmacology. https://doi.org/10.2174/0115701611415264260622061654

Chicago Style (17th ed.) Citation

G, De Luca, et al. "Chronic Treatment with Renin-Angiotensin System Inhibitors at Hospital Admission Is Associated with Improved Reperfusion and Mortality Among STEMI Patients Undergoing Mechanical Reperfusion: Insight from the ISACS-STEMI COVID-19 Registry." Current Vascular Pharmacology 2026. https://doi.org/10.2174/0115701611415264260622061654.

MLA (9th ed.) Citation

G, De Luca, et al. "Chronic Treatment with Renin-Angiotensin System Inhibitors at Hospital Admission Is Associated with Improved Reperfusion and Mortality Among STEMI Patients Undergoing Mechanical Reperfusion: Insight from the ISACS-STEMI COVID-19 Registry." Current Vascular Pharmacology, 2026, https://doi.org/10.2174/0115701611415264260622061654.